We are live on
!
Find out more
AstraZeneca
AZN
AZN
389 hedge funds and large institutions have $7.26B invested in AstraZeneca in 2016 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 136 increasing their positions, 123 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
76% more call options, than puts
Call options by funds: $30.9M | Put options by funds: $17.5M
11% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 123
1.41% more ownership
Funds ownership: 8.79% → 10.2% (+1.4%)
5% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 42
0% more funds holding
Funds holding: 389 → 389 (0)
4% less capital invested
Capital invested by funds: $7.55B → $7.26B (-$285M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
389
Holders Change
–
Holders Change %
0%
% of All Funds
10.37%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
44
Increased
136
Reduced
123
Closed
42
Calls
$30.9M
Puts
$17.5M
Net Calls
+$13.4M
Net Calls Change
+$4.4M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$429M |
| 2 |
Primecap Management
Pasadena,
California
|
+$363M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$127M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$90.5M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$29.7M |
